Management of Anticoagulants and Antithrombotics in Patients With CSDH

University Hospital of Ferrara400 enrolled

Overview

Primary objective of the study will be to compare, up to 6 months after surgery, number of relapses (post operative re-bleeding) or intracerebral hemorrhage (others than subdural hematomas) and thromboembolic or cardiovascular ischemic events, in patients undergoing surgery for chronic subdural hematoma (CSDH). These data will be correlated to the suspension or not of antithrombotics or anticoagulants before surgery or their re-introduction after surgery.

Study Type

OBSERVATIONAL

Enrollment

400

Conditions

Chronic Subdural Hematoma Anticoagulant-induced Bleeding Thromboembolic Stroke Cardiovascular Stroke

Interventions

CSDH evacuation

Eligibility

Sex: ALLMin age: 18 YearsMax age: 95 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age \> 18 years old * Informed consent * Evidence of CSDH which needs surgery * patients taking antithrombotics or anticoagulants Exclusion Criteria: * previous surgery for CSDH

Outcomes

Primary Outcomes

hemorrhagic or thromboembolic events evaluation

hemorrhagic (re-bleedings in surgical field, other cerebral bleedings); thromboembolic events(acute ischemic stroke, acute myocardial infarction, pulmunoray embolism, deep venous thrombosis)

Time frame: up to 6 months after surgery

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.